Adverse Events and the BSRBR-RA Study

by Jessica Emmerson | Sep 11, 2024 | Adverse Events

BSRBR-RA study blog BSRBR-RA Study website 🔗 How are adverse event data collected on the BSRBR-RA Study? An adverse event is “any untoward medical occurrence in a patient being administered a pharmaceutical product, which does not necessarily have a causal...

Register Champions at the BSRBR-RA

by Jessica Emmerson | Sep 2, 2024 | Interview

BSRBR-RA study blog BSRBR-RA Study website 🔗 When did you start recruiting for the RA register? Our site has been recruiting to the BSRBR-RA intermittently since 2003 but the Covid pandemic, the introduction of the online database and the need for regulatory alignment...

Training Sessions at the BSRBR-RA

by Jessica Emmerson | Aug 14, 2024 | Training

  The increasing use of Microsoft Teams for video calling has been really useful for us on the BSRBR-RA study, as it has widened our ability to support our NHS sites and provide useful training. We run three regular training sessions for our sites.   Overview Session...

JAK Inhibitors in the BSRBR-RA

by Jessica Emmerson | Aug 1, 2024 | Biologic Therapy, Research, Study results

BSRBR-RA study blog BSRBR-RA Study website 🔗 Read about some of the recent research from BSRBR-RA looking at JAK inhibitors. Bit of background about you Hello, my name is Zixing Tian, I am an epidemiologist with a research focus on rheumatoid arthritis (RA). I work on...

Working With Patient Support Organisations – Why Is This Important?

by Jessica Emmerson | Jul 25, 2024 | Interview, NRAS

BSRBR-RA study blog BSRBR-RA Study website 🔗 The BSRBR-RA study is fortunate to have strong links with a national patient organisation, National Rheumatoid Arthritis Society (NRAS), and have held numerous focus groups, surveys and meetings with them to ensure that the...